A recent study reveals that people who stop using new GLP-1 drugs like Mounjaro or Wegovy can put back on reduced body mass much more quickly than those who stop conventional diet and exercise plans.
Research printed in a leading health publication demonstrates that while overweight individuals often shed a large proportion of their body weight while using the jabs, the mass returns at an average rate of 0.8 kg per month after stopping.
"Individuals purchasing these drugs need to be cognizant of the potential of quick weight regain when the medication is stopped," stated lead investigator Dr. Susan Jebb.
That rate of regain means a reversion to original mass in about one and a half years.
Weighing Therapies
The study, which examined 37 of studies involving over 9,000 of participants, contrasted the outcomes of the injectable medications with older methods.
Scientists emphasize that individuals who lose weight through dieting usually have a more gradual weight regain—around 0.1 kg a month—once they finish.
Explaining the Quick Regain
Doctors suggest the way of the jabs accounts for the accelerated regain.
These medications copy a body's own chemical called glucagon-like peptide-1, which controls hunger.
"Sustained high doses of the hormone concentrations far above than normal could lead to the body to produce less of its endogenous hormone, and may also lessen responsiveness to its effects," noted Dr. Adam Collins, a nutrition specialist.
"Stopping of this medication means hunger is uncontrolled, making excessive eating much more probable."
An Ongoing Issue?
The NHS recommend the injections for individuals with obesity-related health risks, accompanied by prescribed lifestyle changes.
Professionals contend that, considering the likelihood of relapse, the treatment is often ongoing.
This opinion is reinforced by pharmaceutical companies, who say that the results "highlight the persistent nature of obesity," comparing it to managing diseases like hypertension.
User Testimonies
Users who have come off the medication describe a intense resurgence of hunger.
"It felt as if something that goes on and you're instantly extremely hungry," recalled one woman.
The struggle is exacerbated if individuals have not adopted permanent lifestyle or habit modifications during therapy.
Growing Interest
Survey data show that a significant number of people in the UK have used weight-loss jabs in the past year, with desire remaining high.
- Adoption is greater among females than males.
- The middle-aged demographic shows the highest usage rates.
- A large proportion access the medications through private healthcare rather than public health services.
In conclusion, experts caution that while the jabs are potent agents for weight loss, they are not a magic fix and lasting health benefits hinges on integrated lifestyle support.
